Table 3 Change of secondary outcomes and the results of longitudinal analysis
From: The effect of intradialytic exercise on dialysis patient survival: a randomized controlled trial
Intervention | Usual care | |||||||
|---|---|---|---|---|---|---|---|---|
Baseline (n = 37) | 3rd months (n = 36) | 6th months (n = 35) | Baseline (n = 37) | 3rd months (n = 35) | 6th months (n = 33) | Partial Eta Square | Group× Time | |
Alb (g/dl) | 3.5 ± 0.3 | 3.7 ± 0.3 | 4 ± 0.3 | 3.7 ± 0.3 | 3.6 ± 0.3 | 3.5 ± 0.2 | 0.5 | < 0.001** |
HGB (g/dl) | 10 ± 1 | 10.8 ± 1.3 | 11.7 ± 1.4 | 10.8 ± 1.3 | 10.2 ± 1.2 | 9.9 ± 1.2 | 0.6 | < 0.001** |
RBC (106/µL) | 3.5 ± 0.4 | 3.9 ± 0.5 | 4.2 ± 0.5 | 3.8 ± 0.5 | 3.6 ± 0.5 | 3.5 ± 0.5 | 0.65 | < 0.001** |
HCT (%) | 31.8 ± 3.2 | 34.3 ± 3.4 | 36.8 ± 3.7 | 33.9 ± 3.2 | 32.2 ± 3.1 | 31.1 ± 3 | 0.68 | < 0.001** |
Ca (mg/dl) | 7.9 ± 0.9 | 8.6 ± 7 | 9.1 ± 0.6 | 8.6 ± 0.8 | 8.6 ± 0.7 | 8.3 ± 0.7 | 0.3 | < 0.001** |
P (meq/lit) | 5.6 ± 1.5 | 5 ± 1.2 | 4.3 ± 0.6 | 5.4 ± 1.4 | 5.9 ± 1 | 5.3 ± 1 | 0.3 | < 0.001** |
PTH (pg/ml) | 441 (264—567) | 290 (224—391) | 245 † (173—286) | 270 (180—418) | 342 (245—476) | 312 (243—407) | 0.8 | NA |
GNRI | 92.8 ± 4.6 | 96.1 ± 5.1 | 101.1 ± 4.1 | 96 ± 5.5 | 94.5 ± 4.9 | 92.7 ± 5 | 0.5 | < 0.001** |
6 MWT (m) | 309 ± 86 | 348 ± 92 | 381 ± 99 | 323 ± 78 | 304 ± 83 | 283 ± 87 | 0.9 | < 0.001** |